Evidence map›Paper›PMID 36285507›Full record

ArticleEMBO molecular medicine2022

A high-resolution 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions.

Gordon Wells, Joel N Glasgow, Kievershen Nargan, Kapongo Lumamba, Rajhmun Madansein, Kameel Maharaj, Leon Y Perumal, Malcolm Matthew, Robert L Hunter, Hayden Pacl and 15 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 4 countries.

Gordon WellsAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0003-2328-5208
Joel N GlasgowDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-2842-7917
Kievershen NarganAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Kapongo LumambaAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Rajhmun MadanseinInkosi Albert Luthuli Central Hospital and University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0001-7306-1304
Kameel MaharajInkosi Albert Luthuli Central Hospital and University of KwaZulu-Natal, Durban, South Africa.
Leon Y PerumalPerumal & Partners Radiologists, Ahmed Al-Kadi Private Hospital, Durban, South Africa.
Malcolm MatthewPerumal & Partners Radiologists, Ahmed Al-Kadi Private Hospital, Durban, South Africa.ORCID 0000-0002-1791-9238
Robert L HunterDepartment of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX, USA.
Hayden PaclMedical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-2303-6623
Jacelyn E Peabody LeverMedical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-3490-8474
Denise D StanfordDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-4044-2113
Satinder P SinghDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-5179-0856
Prachi BajpaiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Upender ManneDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-1545-3032
Paul V BensonDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-3819-6884
Steven M RoweDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-9045-0133
Stephan le RouxBruker Belgium NV, Kontich, Belgium.ORCID 0000-0002-5617-8137
Alex SigalAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0001-8571-2004
Muofhe TshibalangandaResearch Group 3D Innovation, Physics Department, Stellenbosch University, Stellenbosch, South Africa.ORCID 0000-0003-1933-5698
Carlyn WellsCT Scanner Facility, Central Analytical Facilities, Stellenbosch University, Stellenbosch, South Africa.
Anton du PlessisResearch Group 3D Innovation, Physics Department, Stellenbosch University, Stellenbosch, South Africa.ORCID 0000-0002-4370-8661
Mpumelelo MsimangDepartment of Anatomical Pathology, National Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Threnesan NaidooAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0002-1864-4301
Adrie J C SteynAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0001-9177-8827
University of Alabama at Birmingham · USAfrica Health Research Institute · ZAStellenbosch University · ZAAddington Hospital · ZANational Health Laboratory Service · ZAUniversity of KwaZulu-Natal · ZABruker (United States) · USThe University of Texas Health Science Center at Houston · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Brian R. Davis · 2007 to 2026
$23.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008361 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YACOUBIAN, TALENE ALENE · 1992 to 2024
$16.8M
Translational Program in CFTR-Related Airway DiseasesR35HL135816 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, STEVEN MARK · 2017 to 2022
$6.3M
Training Program in Lung Biology and Translational MedicineT32HL105346 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAGGAR, AMIT · 2010 to 2025
$5.0M
Hydrogen Sulfide and Tuberculosis DiseaseR01AI134810 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2018 to 2021
$2.2M
Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosisU01HL152978 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, STEVEN MARK · 2021 to 2024
$2.2M
Interplay between the Mtb electron transport chain and carbon metabolismR01AI137043 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2019 to 2023
$2.1M
Heme oxygenase-1 and the bioenergetic threshold of latent TB and HIV co-infectionR01AI111940 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2015 to 2019
$2.0M
METABOLIC REPROGRAMMING OF T CELL ENERGY METABOLISM IN TUBERCULOSIS AND HIVR33AI138280 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2020 to 2023
$2.0M
Mucus Matters: Mucociliary Physiology in Pulmonary FibrosisF31HL146083 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVER, JACELYN EMILY PEABODY · 2019 to 2020
$77k
NHLBI NIH HHS F31 HL146083NHLBI NIH HHS R35 HL135816NHLBI NIH HHS T32 HL105346NHLBI NIH HHS U01 HL152978NIAID NIH HHS R01 AI111940NIAID NIH HHS R01 AI134810NIAID NIH HHS R01 AI137043NIAID NIH HHS R33 AI138280NIDDK NIH HHS P30 DK072482NIGMS NIH HHS T32 GM008361Wellcome Trust
6 · The paper itself

Abstract

Our current understanding of the spectrum of TB and COVID-19 lesions in the human lung is limited by a reliance on low-resolution imaging platforms that cannot provide accurate 3D representations of lesion types within the context of the whole lung. To characterize TB and COVID-19 lesions in 3D, we applied micro/nanocomputed tomography to surgically resected, postmortem, and paraffin-embedded human lung tissue. We define a spectrum of TB pathologies, including cavitary lesions, calcium deposits outside and inside necrotic granulomas and mycetomas, and vascular rearrangement. We identified an unusual spatial arrangement of vasculature within an entire COVID-19 lobe, and 3D segmentation of blood vessels revealed microangiopathy associated with hemorrhage. Notably, segmentation of pathological anomalies reveals hidden pathological structures that might otherwise be disregarded, demonstrating a powerful method to visualize pathologies in 3D in TB lung tissue and whole COVID-19 lobes. These findings provide unexpected new insight into the spatial organization of the spectrum of TB and COVID-19 lesions within the framework of the entire lung.

Indexed as

COVID-19Mycobacterium tuberculosisTuberculosisHumansLungTomography, X-Ray ComputedcalcificationCOVID-19granulomathrombosistuberculosis

Identifiers

PMID36285507
PMCPMC9641421
OpenAlexW4307341701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.